Overcoming kinase resistance in chronic myeloid leukemia-Reference-Cited by-同舟云学术

Overcoming kinase resistance in chronic myeloid leukemia

Published:2008-01 Issue:3 Volume:40 Page:334-343
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Lee Francis,Fandi Abderrahim,Voi Maurizio

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference71 articles.

1. Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia;Barnes;Acta Haematol.,2002

2. Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells;Bartholomeusz;Blood,2007

3. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors;Buchdunger;J. Pharmacol. Exp. Ther.,2000

4. Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development;Burchert;Leukemia,2005

5. Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump;Burger;Blood,2004

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells;International Journal of Oncology;2024-02-27

2. Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation;European Journal of Medicinal Chemistry;2021-11

3. Design, synthesis, and biological evaluation of novel bromo-pyrimidine analogues as tyrosine kinase inhibitors;Arabian Journal of Chemistry;2021-04

4. Anti‐leukemic effect of PI3K inhibition on chronic myeloid leukemia (CML) cells: shedding new light on the mitigating effect of c‐Myc and autophagy on BKM120 cytotoxicity;Cell Biology International;2020-05

5. Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase;Journal of Medicinal Chemistry;2019-09-20